ASCL1 and neoplasm: We next asked whether LATSi can reverse the fully established NEPC tumor phenotype that develops in vivo by establishing ASCL1+ tumoroids from NEPC tumors that developed following orthotopic transplantation of RPM and TKO organoids (see methods for details) (Fig S4B–E).